METHODS: The related BPES patients underwent a comprehensive ocular examination. Next, whole-exome sequencing (WES) was performed to screen for the disease-causing genetic variants. A step-wise variant filtering was performed to select candidate variants combined with the annotation of the variant\'s pathogenicity, which was assessed using several bioinformatic approaches. Co-segregation analysis and Sanger sequencing were then conducted to validate the candidate variant.
RESULTS: The variant c.672_701dup in FOXL2 was identified to be the disease-causing variant in this rare BPES family. Combined with clinical manifestations, the two affected individuals were diagnosed with type II BPES.
CONCLUSIONS: This study uncovered the variant c.672_701dup in FOXL2 as a disease causal variant in a rare-presenting BPES family with anisometropia, unilateral pathogenic myopia, and/or congenital cataracts, thus expanding the phenotypic spectrum of FOXL2.
方法:对相关的BPES患者进行全面的眼部检查。接下来,进行全外显子组测序(WES)以筛选致病遗传变异.进行逐步变体过滤以选择候选变体,并结合变体致病性的注释,这是使用几种生物信息学方法进行评估的。然后进行共分离分析和Sanger测序以验证候选变体。
结果:FOXL2中的变异c.672_701dup被鉴定为这个罕见的BPES家族中的致病变异。结合临床表现,两名受影响的个体被诊断为II型BPES.
结论:这项研究发现FOXL2中的变异c.672_701dup是罕见的BPES家族中的疾病因果变异,单侧致病性近视,和/或先天性白内障,从而扩大了FOXL2的表型谱。